Used as a key intermediate in the synthesis of boron-containing pharmaceuticals, particularly in the development of protease inhibitors. Its cyclic boronate structure enables selective binding to enzyme active sites, making it valuable in drug design for antiviral and anticancer agents. Also employed in chiral catalysis and asymmetric synthesis due to its stable stereochemistry and ability to direct enantioselective transformations.